Back
Day Range
$75.89
$80.74
52-Week Range
$19.45
$103.00
Volume
674,359
50D / 200D Avg
$79.67
/
$61.62
Prev Close
$77.91
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (626 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -20.2 | 0.4 |
| P/B | 4.0 | 2.9 |
| ROE % | -25.8 | 3.8 |
| Net Margin % | -794.4 | 3.9 |
| Rev Growth 5Y % | -14.4 | 10.0 |
| D/E | 0.1 | 0.2 |
Key Takeaways
Revenue declined -14.35% annually over 5 years
Debt/Equity of 0.05 — conservative balance sheet
Negative free cash flow of -234.34M
Capital efficient — spends only 3.70% of revenue on capex
Growth
Revenue Growth (5Y)
-14.35%
Revenue (1Y)-16.72%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
-25.79%
ROIC-15.77%
Net Margin-794.39%
Op. Margin-891.33%
Safety
Debt / Equity
0.05
Current Ratio10.47
Interest Coverage-1403.21
Valuation
P/E Ratio
-20.18
P/B Ratio3.98
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -16.72% | Revenue Growth (3Y) | -29.38% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | -14.35% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 39.20M | Net Income (TTM) | -311.40M |
| ROE | -25.79% | ROA | -17.87% |
| Gross Margin | 100.00% | Operating Margin | -891.33% |
| Net Margin | -794.39% | Free Cash Flow (TTM) | -234.34M |
| ROIC | -15.77% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.05 | Current Ratio | 10.47 |
| Interest Coverage | -1403.21 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -20.18 | P/B Ratio | 3.98 |
| P/S Ratio | 160.29 | PEG Ratio | -0.89 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 6.28B | Enterprise Value | 6.01B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 39.20M | 47.07M | 78.59M | 46.83M | 72.83M |
| Net Income | -311.40M | -223.86M | -146.96M | -154.81M | -100.22M |
| EPS (Diluted) | -3.69 | -2.98 | -2.52 | -2.87 | -2.09 |
| Gross Profit | 39.20M | 47.07M | 78.59M | 46.83M | 72.83M |
| Operating Income | -349.40M | -261.64M | -165.53M | -161.26M | -100.53M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 1.74B | 978.04M | 575.76M | 603.13M | 605.91M |
| Total Liabilities | 163.15M | 142.42M | 180.79M | 112.98M | 146.27M |
| Shareholders' Equity | 1.58B | 835.62M | 394.97M | 490.15M | 459.64M |
| Total Debt | 82.25M | 87.76M | 84.67M | 17.34M | 17.96M |
| Cash & Equivalents | 357.01M | 120.26M | 109.97M | 68.40M | 47.98M |
| Current Assets | 871.21M | 510.27M | 405.32M | 419.42M | 451.27M |
| Current Liabilities | 83.21M | 67.77M | 85.69M | 71.34M | 92.54M |